About Cervical Cancer Diagnostic Tests Cervical cancer diagnostic tests are used to identify the presence of the precancerous or cancerous lesions in the cervix of a woman. These tests include an initial screening using pap smear and HPV testing, and upon positive results, colposcopy and biopsy are further utilized to confirm the diagnosis. After the positive diagnosis, the patient is further subjected to imaging tests that are used to establish the grade of cancer. TechNavio's analysts forecast the Global Cervical Cancer Diagnostic Tests market to grow at a CAGR of 10.89 percent over the period 2013-2018. Covered in this Report The report covers the present scenario and the growth prospects of the Global Cervical Cancer Diagnostic Tests market for the period 2014-2018. To calculate the market size, the report considers the revenue generated from the sales of the following diagnostic test kits and instruments used to diagnose cervical cancer: • Pap Smear Test • HPV Testing • Colposcopy • Biopsy In addition, the report includes the type of method used to identify cervical cancer: • Molecular method • Cytopathological method • Physical method Technological types used in cervical cancer identification are also discussed in this report: • ELISA • FISH • NASBA • PCR • Staining & Microscopy • Optical Imaging TechNavio's report, the Global Cervical Cancer Diagnostic Tests Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the APAC and EMEA regions; it also covers the Global Cervical Cancer Diagnostic Tests market landscape and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market. Key Regions • Americas • APAC • EMEA Key Vendors • Abbott Laboratories • Becton Dickinson • Hologic • Qiagen • Quest Diagnostics • Roche Diagnostics Other Prominent Vendors • Anthera Pharmaceuticals • Arbor Vita • Autogenomics • Biolight Meditech • BioMerieux • Biovantra • Cancer Genetics • Cervia Diagnostics • Centrel • Cooper Surgical • Cytoimmun • DySIS Medical • Edan • Femasys • Greiner Bio One • Guided Therapeutics • Incell dx • Innogenetics • Kernel Medical • Lutech Industries • Medgyn • Micromedic Technologies • Norchip • Olympus Medical • OncoHealth Corp • Optomic • Optopol Technology • Shenzhen Goldcare Meditech • Sunray • Zilico Market Driver • Increased Incidence of Smoking • For a full, detailed list, view our report Market Challenge • Lack of Awareness • For a full, detailed list, view our report Market Trend • Development of New Diagnostic Platforms • For a full, detailed list, view our report Key Questions Answered in this Report • What will the market size be in 2018 and what will the growth rate be? • What are the key market trends? • What is driving this market? • What are the challenges to market growth? • Who are the key vendors in this market space? • What are the market opportunities and threats faced by the key vendors? • What are the strengths and weaknesses of the key vendors?
SIMILAR MARKET STUDIES
2016 Germany Hemostasis Diagnostics Market: Reagent and Instrument Supplier Shares, Country Volume and Sales Segment Forecasts, Innovative Technologies, Instrumentation Review, Competitive Strategies, Emerging Opportunities (DataPack)
This DataPack contains tables from VPGMarketResearch.com new report, 2016 Germany Hemostasis Diagnostics Market: Reagent and Instrument Supplier Shares, Country Volume and Sales Segment Forecasts, Innovative Technologies, Instrumentation Review, Competitive Strategies, Emerging Opportunities. For pricing information on DataPack sections or individual tables, please contact Customer Service.
February 2016 | $0 | View Details >>
This new seven-country study from VPGMarketResearch contains 1,398 pages, 194 tables, and is designed to help current suppliers and potential market entrants identify and evaluate major business opportunities emerging in the molecular diagnostics market during the next five years. Highlights- Business and technological trends in seven major markets: France, Germany, Italy, Japan, ...
November 2015 | $15900 | View Details >>
2016 Iceland Tumor Marker Diagnostics Market: Emerging Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains-Test Volume and Sales Forecasts, Competitive Strategies, Opportunities
This new report from VPGMarketResearch.com provides a strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years. The report examines emerging trends in the cancer diagnostics market; reviews current and emerging tests; analyzes potential applications of innovative technologies; forecasts volume and sales ...
February 2016 | $0 | View Details >>
This new report provides analysis of Free Light Chains testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment.
November 2014 | $0 | View Details >>
UPCOMING MARKET RESEARCH REPORTS
2017 © Copyright Big Market Research